News & Blog

Tag Archives: FDA

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

Brain Tumor News From the 2015 American Society for Clinical Oncology Meeting

From May 29 – June 2, National Brain Tumor Society Research and Scientific Operations staff attended the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the most important cancer research meetings of the year. Each year, we attend ASCO to learn about the latest research on emerging new treatments and get updates on […]

National Brain Tumor Society’s 2015 Legislative Agenda

To guide our public policy advocacy efforts each year, National Brain Tumor Society creates an annual “Legislative Agenda.” Our yearly Legislative Agenda reflects the larger strategy and goals of the Organization, and our activities in carrying out the agenda directly influences our ability to deliver on our mission of better treatments, and ultimately a cure, […]

Share